Skip to content

Exemestane

Exemestane (Aromasin) is an aromatase inhibitor used in breast cancer treatment. This single-product page covers the Aromasin 25mg tablet, the only formulation listed in this catalogue.

Aromasin

Breast Cancer

25mg

Exemestane tablets for breast cancer. It lowers oestrogen levels in postmenopausal women by permanently blocking the aromatase enzyme.

From$3.56/ tabletView

Key points

  • Aromatase inhibitors reduce oestrogen levels in the body, and Exemestane belongs to this class of medicine.
  • The Aromasin 25mg tablet is the originator brand from Pfizer, presented as a single-ingredient product.
  • In breast cancer, Exemestane can slow or stop the growth of tumours that depend on oestrogen to grow.

Exemestane is marketed by Pfizer under the brand name Aromasin. The 25mg tablet is the only formulation listed in this catalogue for breast cancer treatment. exemestane is a single-ingredient product, not a combination therapy.

Further reading